Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 372

1.

Hypoxia-inducible factor-1alpha induces the epithelial-mesenchymal transition of human prostatecancer cells.

Luo Y, He DL, Ning L, Shen SL, Li L, Li X.

Chin Med J (Engl). 2006 May 5;119(9):713-8.

PMID:
16701010
2.

[Over-expression of HIF-1alpha induces EMT of human prostate cancer cells].

Luo Y, He DL, Jiang YG, Li MC, Ning L, Shen SL.

Zhonghua Nan Ke Xue. 2008 Sep;14(9):800-4. Chinese.

PMID:
18998463
3.

Over-expression of hypoxia-inducible factor-1alpha increases the invasive potency of LNCaP cells in vitro.

Luo Y, He DL, Ning L, Shen SL, Li L, Li X, Zhau HE, Chung LW.

BJU Int. 2006 Dec;98(6):1315-9. Epub 2006 Sep 6.

4.

[Over-expression of Hypoxia-inducible factor 1alpha increases invasive potency of LNCaP cells in vitro].

Luo Y, He DL, Ning L, Shen SL, Li L, Li X.

Zhonghua Yi Xue Za Zhi. 2006 Aug 29;86(32):2285-8. Chinese.

PMID:
17064578
5.

[Role of beta-catenin signaling pathway in EMT of human prostate cancer induced by HIF-1alpha].

Luo Y, He DL, Jiang YG, Ning L, Shen SL, Zhao JH, Cui XH.

Zhonghua Yi Xue Za Zhi. 2010 Apr 27;90(16):1131-6. Chinese.

PMID:
20646434
6.

[Over-expression of hypoxia-inducible factor-1 alpha increases angiogenesis of LNCaP cells].

Han YL, He DL, Luo Y, Cheng HP, Zhu GF.

Zhonghua Nan Ke Xue. 2007 Nov;13(11):988-91. Chinese.

PMID:
18077909
7.

[Over-expression of hypoxia-inducible factor-1alpha induces epithelial-mesenchymal transition in LNCaP cells in vitro and in vivo].

Han YL, Luo Y, He DL, Cheng YY, Xu YG.

Zhonghua Nan Ke Xue. 2012 Jan;18(1):23-8. Chinese.

PMID:
22295844
8.
9.

[Over-expression of hypoxia-inducible factor 1 alpha increases angiogenesis of LNCaP cells in vivo].

Han YL, He DL, Luo Y, Cheng HP, Zhu GF.

Zhonghua Nan Ke Xue. 2008 May;14(5):439-44. Chinese.

PMID:
18572865
11.

[Influence of hypoxia inducible factor-1alpha on cervical cancer cell line HeLa in vitro].

Cheng YX, Pu DM, Liu R, Li T, Yin L, Ma D.

Zhonghua Fu Chan Ke Za Zhi. 2007 Aug;42(8):551-4. Chinese.

PMID:
17983496
12.

[Epithelial-mesenchymal transition of prostate cancer: cancer stem cells or bulk cancer cells].

Luo Y, Cui XH, Jiang YG, He DL, Zhao JH, Zhao L, Chen YT, Li MC, Lin YH.

Zhonghua Yi Xue Za Zhi. 2013 Jan 22;93(4):256-60. Chinese.

PMID:
23578503
13.

Localization of immunoreactive HIF-1alpha and HIF-2alpha in neuroendocrine cells of both benign and malignant prostate glands.

Monsef N, Helczynski L, Lundwall A, Påhlman S; Anders-Bjartell..

Prostate. 2007 Aug 1;67(11):1219-29.

PMID:
17562539
14.

[Transforming growth factor beta upregulates the expression of invasion and metastasis associated proteins in prostate cancer LNCaP cell lines in vitro].

Zhu GF, Cheng HP, Wu KJ, Zhang LL, Zhu GD, Zhang D, He DL.

Zhonghua Nan Ke Xue. 2008 Mar;14(3):238-41. Chinese.

PMID:
18488338
15.

Human hormone-refractory prostate cancers can harbor mutations in the O(2)-dependent degradation domain of hypoxia inducible factor-1alpha (HIF-1alpha).

Anastasiadis AG, Ghafar MA, Salomon L, Vacherot F, Benedit P, Chen MW, Shabsigh A, Burchardt M, Chopin DK, Shabsigh R, Buttyan R.

J Cancer Res Clin Oncol. 2002 Jul;128(7):358-62. Epub 2002 May 16.

PMID:
12136249
16.

Expression of c-ets-1 mRNA is associated with an invasive, EMT-derived phenotype in breast carcinoma cell lines.

Gilles C, Polette M, Birembaut P, Brünner N, Thompson EW.

Clin Exp Metastasis. 1997 Sep;15(5):519-26.

PMID:
9247254
17.

Ets-1 and hypoxia inducible factor-1alpha inhibition by angiotensin II type-1 receptor blockade in hormone-refractory prostate cancer.

Kosaka T, Miyajima A, Shirotake S, Kikuchi E, Hasegawa M, Mikami S, Oya M.

Prostate. 2010 Feb 1;70(2):162-9. doi: 10.1002/pros.21049.

PMID:
19760626
18.

Increased expression of hypoxia inducible factor-1alpha in rat and human prostate cancer.

Zhong H, Agani F, Baccala AA, Laughner E, Rioseco-Camacho N, Isaacs WB, Simons JW, Semenza GL.

Cancer Res. 1998 Dec 1;58(23):5280-4.

19.

Hypoxic regulation of PFKFB-3 and PFKFB-4 gene expression in gastric and pancreatic cancer cell lines and expression of PFKFB genes in gastric cancers.

Bobarykina AY, Minchenko DO, Opentanova IL, Moenner M, Caro J, Esumi H, Minchenko OH.

Acta Biochim Pol. 2006;53(4):789-99. Epub 2006 Dec 4.

20.

Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells.

Veveris-Lowe TL, Lawrence MG, Collard RL, Bui L, Herington AC, Nicol DL, Clements JA.

Endocr Relat Cancer. 2005 Sep;12(3):631-43.

Supplemental Content

Support Center